HeartBeam wins new U.S. patent expanding cable-free ECG device sensing capabilities

• HeartBeam received allowance of a new U.S. patent covering acoustic sensing and thoracic-impedance measurement integrated into its credit card-sized, cable-free ECG device.
• Patent expands the platform into heart-sound monitoring and chest-fluid tracking, targeting structural heart disease screening and earlier heart-failure intervention.
• Claims cover acoustic sensors built into the device’s foldable arms, positioning it for use as a digital stethoscope without changing the form factor.
• Claims also cover thoracic-impedance measurement using finger electrodes to inject current, measuring voltage across chest electrodes to estimate fluid in the chest.
• Company said it now holds 26 issued patents worldwide across ECG signal acquisition, synthesis algorithms, diagnostic applications, device hardware, and an on-demand 12-lead patch.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartbeam Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260714128308) on July 14, 2026, and is solely responsible for the information contained therein.